InVera Medical
@inveramedical.com
InVera Medical™ is a medical device company developing the next-generation medical device treatment for all venous disease patients. Formerly known as Venari Medical. Our InVera™ device is a more effective, less invasive, and faster treatment for all venous disease patients. It is uniquely positioned to disrupt current treatment practices which have seen only medium level innovation in the past decade. The team is based at Ireland's medtech cluster in Galway. Only 1.3 million of the 120 million people in the US & EU who suffer from venous disease currently receive endovenous treatment each year. 3 million venous ulcer patients are completely unserved, using ineffective compression bandaging. InVera Medical™ offers an unrivalled lower risk and unparalleled effective non-thermal treatment which will allow more patients who suffer from Venous Disease to access effective treatment. The indication for the use of superficial venous ablation is also set to widen to treat venous ulcers which currently incur annual costs of $33Bn to insurers in the US & EU. The InVera™ technology can be used as a safe and effective treatment for the whole spectrum of Venous Disease from varicose veins to active venous ulcers.
InVera Medical's Company Logos
InVera Medical's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#33A7B5
Pelorous
51, 167, 181
186, 56, 45
72, 8, 0, 29
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#000000
Black
0, 0, 0
0, 0, 0
0, 0, 0, 100
About InVera Medical
Introducing InVera Medical™, the revolutionary brand behind the world's first medical device that harnesses the body's own biological response to effectively and safely treat varicose veins and venous ulcers. InVera™ offers a breakthrough treatment for chronic venous disease, providing a less-invasive, pain-free, and faster solution for patients. Unlike traditional therapies, InVera™ utilizes the body's natural healing response without any harmful side effects.
With the aim to improve the quality of life for sufferers, our innovative device treats symptoms and allows all chronic venous disease patients to receive treatment for the first time. As the 4th most common chronic disease worldwide, venous disease places a significant burden on healthcare systems. InVera™ addresses this unmet clinical need by offering a lower-risk treatment option, which is anticipated to receive regulatory approval in 2024.
Join us in our mission to transform the treatment of chronic venous disease and make a positive impact on patient lives. Contact the InVera Medical™ team at info@inveramedical. com
Company type
Privately Held
Year founded
2018
Company size
2-10 employees
